Bill Gates Speech to the Sixty-fourth World Health Assembly

Bill gates at the World Health Assembly

Mr Bill Gates: co-chair of the Bill & Melinda Gates Foundation

Mr. President, Prime Minister Sheikh Hasina, Director-General Dr. Margaret Chan, Excellencies, ladies and gentlemen.

The World Health Organization and this assembly have set the standard for global cooperation in pursuit of better health. For decades, you have established ambitious goals, such as eradicating smallpox. And you have rallied the world to accomplish those goals. It is an honor to join you today.

I had the privilege of addressing this assembly in 2005, when my wife Melinda and I were new to global health. At that time, we were so optimistic about the future. The world was finally starting to use its greatest resource, innovation, to solve this difficult problem – the fact that billions of people don’t have the chance to lead a healthy, productive life.

In the past six years, my optimism has continued to grow.

An recent important new book Getting Better by the economist Charles Kenny shows that life is getting better, rapidly, for people in poor countries. To build his argument, he examines a series of key quality-of-life indicators, including child survival, school enrollment, and levels of violence.

I hope this book gets the acclaim it deserves. It proves that the great work this assembly has been leading is having an enormous impact. We need the people who make funding decisions and set policy to understand the progress being achieved every day. I believe we have the opportunity to make even more progress, faster, for more people.

This opportunity is the reason I devoted my time to the Gates Foundation. Health and development is the most rewarding work I can think of, and Melinda and I will devote the rest of our lives to it.

When I was a teenager, I was captivated by computers because I believed they would change the world. I couldn’t predict exactly what the future would look like, but I was amazed by a sense to improve and empower.

Over the years, as I watched so much change taking root, I also saw glimpses of what was not changing. In 1994, I traveled to sub-Saharan Africa. It was impossible to ignore the devastating impact of disease and poverty on people’s lives.

Then, in 1998, Melinda and I read an article about rotavirus. We learned that it was the leading cause of diarrhea in young children – and that it caused 500 000 deaths annually. Our first child had just been born, and there was a good chance she’d suffered from rotavirus. But in the United States, children don’t die from diarrhea, so this was not a worry for us.

We’d never been forced to reckon with rotavirus, in fact, we’d never even heard of it because there was no chance our daughter would be killed by it.

This was a sobering realization for me. I had built my life around the idea that innovation is for everyone. When I began to understand how billions of people are deprived of its benefits, it made me angry. That’s when I decided to use my personal wealth would be used to help confront that inequity.

Thirty years ago, when I founded Microsoft my colleagues and I envisioned a computer for everyone. Now, I join you in seeking good health care for every human being.

At the Gates Foundation, our goal is to spur innovation on health problems.

Our priorities are your priorities: to make motherhood safer; to ensure that newborns survive their first 30 days; to provide children with a nutritious diet.

We see what you see everyday – that diseases like HIV, tuberculosis, and malaria can destroy communities. Along with great partners like the Global Fund, we want to help you diagnose, treat, and above all, prevent disease.

As we think about how to deploy our resources most effectively, one intervention stands out: vaccines.

Today, I would like to talk about how you can provide the leadership to make this the Decade of Vaccines.

Vaccines are an extremely elegant technology. They can be inexpensive, they are easy to deliver, and they are proven to protect children lifelong from disease. At Microsoft, we dreamed about technologies that were so powerful and yet so simple. Today, I like to imagine what the future will look like when world leaders start to take full advantage of vaccines.

In this Decade, we can achieve a lot.

Early in this decade, we will eradicate polio.
By the end of the decade, five or six new vaccines will be available to all children of the world.
And, crucially, every country in the world will have built a delivery system made to get vaccines to every last child.

To put an end to polio and reach all children with new vaccines, we must create strong immunization programmes.

In January of last year, I called for the world to accelerate progress on vaccines. That was a moment, and now there is momentum. I’m excited that global health leaders are now collaborating to put a specific global vaccine action plan in place.

The success of that plan will be a blueprint for the success of the Decade of Vaccines. It will depend on us to do our best work.
Vaccines and immunization

The greatest asset of every country is the energy and talent of its people. Disease saps that energy and squanders that talent. Repeated intestinal infections stunt children’s growth and reduce their cognitive development. Meningitis can cause permanent neurologic disability. Malaria prevents people from being productive; over a lifetime, high rates of malaria are cause substantially reduced earnings.

That’s why vaccines are one of the best investments we can make in the future: healthy people drive thriving economies. As we free billions of people from the relentless burden of sickness and death will unleash more human potential than ever before.

Let me give you an example of the difference vaccines can make.

This year, 20 million children will have severe pneumonia. More than a million will die. But even when the disease doesn’t take a child’s life, it can affect the child’s and family’s future.

For the survivors, the sickness reduces their chances of growing up healthy and strong. Their parents will go into debt. But we now have vaccines against two of the leading causes of pneumonia which make it possible for countries to reduce the burden and tap into people’s energy and nurture their talent.
Product development

The pneumonia vaccines are a symbol of one of the most exciting trends in global health, the drive towards equity in delivering innovations.

In the past, innovations developed vaccines for rich countries, and it took more than a decade before they were introduced in poor countries. But that is changing.

The newest pneumonia vaccines were available in developing countries only a few years after they were approved for use in developed countries. The same is true of a new rotavirus vaccine. But approved and available don’t mean delivered. Now it is up to the GAVI Alliance and many of you in this room to ensure that these vaccines reach the children who need them.

Last December, Burkina Faso, Mali, and Niger made history when they introduced a brand new vaccine for Meningitis A, the first vaccine developed specifically for use in Africa.

The story began in 1996, when the deadliest meningitis epidemic in memory tore through 25 countries in Africa, infecting more than 250 000 people. Meningitis strikes with frightening speed. A perfectly healthy child can be playing with friends one minute and literally be dead a few hours later.

In 1996, the only weapon against meningitis was barely useful at all, a short-lasting vaccine that wasn’t effective among young children. Health officials used it to control outbreaks that were already raging, so they called it “medicine after death.” They demanded a better vaccine that could prevent outbreaks.

The WHO and an organization called PATH formed the Meningitis Vaccine Project in 2001. The partners set a target price of 50 cents for the vaccine, which would make it affordable.

But producing a vaccine at that low price required a new approach to drug development. The Meningitis Vaccine Project worked with a Dutch biotech company to obtain key raw materials and arranged a technology transfer from the United States. Then, the Serum Institute of India agreed to manufacture the vaccine at the target price.

I am pleased to announce that we now have very early results from the use of vaccines from Burkina Faso. In the first 16 weeks of this year, there was just a single case of meningitis reported in the country.

It’s too soon to declare victory, but the early data makes me hopeful. For centuries, meningitis terrorized a region of 400 million people. This vaccine can help end the terror.

We need to continue creating and delivering more vaccines, but finally, for the first time, we can see a bright future.
Vaccine coverage

To keep the promise of equitable access to health care, all new vaccines must be priced low enough so that all countries can afford them. The Gates Foundation is working with many vaccine manufacturers to ensure that vaccines are available at a reasonable price. I believe that we can cut the combined price of the pentavalent, pneumococcus, and rotavirus vaccines in half by 2016.

But even when prices are fair, delivering vaccines to every child takes a great commitment.

Many developing countries are already doing a great job. Bangladesh, Nicaragua, Rwanda, and Vietnam routinely reach about 90 percent of their infants. But there are many places where vaccination rates are low. Almost every country can do better, must do better, if this decade is to reach the potential of the Decade of Vaccines.

Leading a health ministry is a hard job. You face a multitude of complicated choices. The stakes are always life and death and you have many priorities.

But you all have access to one key resource: your own leadership. And leadership can be decisive. The best immunization systems work because leaders hold themselves accountable for results. They diagnose problems, innovate to solve them, and spread the best ideas.

Let me give an example. Just a few years ago, the Indian state of Bihar was vaccinating under 30 percent. Then, a new chief minister, Nitish Kumar, was elected, and he made it clear that he expected change.

So even though Bihar is still one of the most challenging places in the world, but it’s no longer one of the least vaccinated. Under Chief Minister Kumar, the vaccination rate has more than doubled, and it plans to go higher.

I visited with Chief Minister Kumar two months ago, and his understanding of what was working and what wasn’t was impressive. He understood the innovations that were being tested.

Examples like this inspire all of us for better leadership. I was also struck by the chief minister’s popularity. People are hungry for visionary leaders who not only promise a better future, but take a basic system and make it work.

Today, I ask for your leadership. In 2005, you set two critically important immunization-related goals that we have not yet reached.

Let us renew our pledge that no country will be below 90 percent coverage. Let us rededicate ourselves to the idea that no district will be below 80 percent coverage. We will meet those goals if, and only if, you lead. With your leadership, you will make this the Decade of Vaccines.

As a global health community, it is imperative that we shine a light on the countries doing the best work. We need to know who the innovators are, so that the most powerful ideas spread far and wide.

Starting in 2012, the Gates Foundation will bestow an award on the individual or organization that has made the most uniquely innovative contribution to the Decade of Vaccines. This could be innovation in the science, delivery, or funding of vaccines. I will announce the winner every January in my annual letter. My goal is to make sure that pioneering global health leaders get the credit they deserve.
Polio

The long fight against polio proves just how powerful vaccine technology can be, but it also demonstrates that it is only as effective as the quality of delivery.

Twenty-three years ago, here in this building, the delegates to this Assembly resolved to wipe polio off the planet. And now we’re 99 percent of the way there, because of two things: a 13 cent vaccine so easy to administer that even I have done it many times; and the most impressive, farthest-reaching delivery effort global health has ever seen.

It is fantastic that more than 100 countries no longer have polio. In the most difficult conditions in the world, we are making stunning progress. Despite the ongoing war, Afghanistan has had only one case this year.

But progress is not the same as success, and eradication is not guaranteed. We have tools: diagnostics, surveillance systems, and vaccines that are constantly being improved, but the virus keeps spreading back into countries where it had been eliminated. There are countries where the virus continues to circulate, despite multiple campaigns every year. Globally, the polio programme is not assured of funding to keep running campaigns and improving vaccination systems.

These discouraging facts raise a question: do we really have the political commitment to eradicate polio?

Are donor countries, especially the G8, ready to close today’s funding gap and see the job through to the very end?

Are the countries where polio still exists ready to take extraordinary action to reach every single child with the vaccine?

We have a choice. We can keep doing what we’ve been doing, immunizing the same children over and over and missing the children who are the most vulnerable. Or we can do more. We can step up our fundraising, we can intensify our campaigns, and we can do what it takes to get to zero cases. If we make that choice, we will prove that people are capable of coming together to solve complex, worldwide problems.

The eradication of polio will be a great victory for this Assembly. You started the courageous fight against this disease. You will finish it. And then you will be able to move on to the next ambitious goal.

One of the polio leaders I respect most is Dr. Muhammad Pate, who directs Nigeria’s national eradication effort. Just a few years ago, Nigeria was the most troublesome spot on the polio map. It had hundreds of cases. Much worse, it lacked the commitment to bringing that number down.

But Dr. Pate, along with the global polio partners, President Goodluck Jonathan, and members of the ministry of health, helped rally government and traditional leaders around the cause. Dr. Pate told me that his agency makes a point of identifying poor-performing states publicly. That’s the kind of accountability that leads to results. Last year, thanks to a nationwide effort, polio was down 95 percent in Nigeria. Nigeria’s leaders still have a lot of work ahead of them, but they have turned the polio programme around.

During my last visit to Nigeria, Dr. Pate asked me a small favor. He hoped I’d be willing to sign his daughter’s school yearbook. I was more than willing, of course, and I want Dr. Pate’s daughter to know this: I admire her father very much, I want to someday introduce my children to him one day soon, and I hope more than anything that when that day comes we shall be celebrating the fact that there is no more polio in Nigeria.
Call to action

The world has a great opportunity right now, and whether or not we seize it will depend in large part on those of us in this room. It will depend on our ability to do the difficult, necessary things to usher in the Decade of Vaccines.

Donor countries, will have to increase investment in vaccines and immunization, even though they are coping with budget crises. The GAVI Pledging meeting in June gives you and your governments the opportunity to show your support. If donors are generous, we will prevent 4 million deaths by 2015. By 2020, we can prevent 10 million deaths.
Pharmaceutical companies, you must make sure vaccines are affordable for poor countries. Specifically, you must make a commitment to tiered pricing.
For all 193 Member States, you must make vaccines a high priority focus of your health systems, to ensure that all your children have access to existing vaccines now, and to new ones that have recently become available.

At the Gates Foundation, we are committed to working with all our partners – civil society, donors, drug companies, and national governments – to help you do the difficult but necessary things.

I am confident because I’ve seen so many examples of leadership.

British Prime Minister David Cameron passed the toughest austerity budget in his country’s memory. Yet, in the face of enormous pressure, he kept his promise to maintain development spending. A few months later, he announced that the United Kingdom would double its commitment to the polio campaign.

Another example is the Serum Institute of India, led by Dr. Cyrus Poonawalla, has broken the mold for the low-cost manufacture of vaccines. They developed the meningitis vaccine, they are the world’s largest producer of the measles vaccines, and they provide the pentavalent vaccine to GAVI at a lower price than any other manufacturer in the world. In the coming years they will manufacture inexpensive diarrhea and pneumonia vaccines.

Nitish Kumar and Muhammad Pate and many others have demonstrated that the best leaders can overcome tough challenges.

Together, and with your leadership, we can make this the decade in which we take full advantage of the technology of vaccines. When we do it, we will build an entirely new future based on the understanding that global health is the cornerstone of global prosperity.

It might be the most difficult thing we’ve ever done, but it will also be the most important.

Thank you.

nn

Share

UN-backed Partners Help DR Congo Introduce Pneumonia Vaccine

4 April 2011 –The Democratic Republic of the Congo (DRC) today added the vaccine against pneumonia to its national immunisation programme in a United Nations-backed initiative to drastically improve the chances of survival for children under the age of five.

The expanded programme is supported by the Global Alliance for Vaccines and Immunisation (GAVI), which brings together governments, the UN Children’s Fund (UNICEF), the World Health Organization (WHO) and other key players in global health.

It will initially be rolled out in two of DRC’s 11 provinces as the country steps up the fight against pneumonia, one of the biggest killers of children worldwide, and is responsible for a quarter of all deaths of children under the age of five in the African nation.

DRC’s First Lady, Olive Lembe Kabila, and Health Minister Victor Makwenge Kaput joined parents and health workers in Kinshasa to witness the first child being inoculated as part of the official introduction of pneumococcal vaccine into the national routine immunization programme.

On the same day in Paris, GAVI founding partner Bill Gates launched a European-wide awareness campaign to highlight the extraordinary life-saving opportunity that vaccines represent for donor countries.

Globally, pneumococcal disease, the most common and serious form of respiratory infections, kills over a million people every year – including more than half a million children before their fifth birthday.

It is the leading cause of pneumonia, which is the major cause of death among children under the age of five, contributing to 18 per cent of the mortality of children in that age group.

“Today’s launch is an enormous moment for my country, where too many children die of this terrible disease,” said Mr. Kaput. “Pneumonia causes suffering and death. Therefore we celebrate a wonderful day today.”

Léodégal Bazira, the acting WHO Representative in DRC, said: “The introduction of the pneumococcal vaccine and the systematic immunization of the children could save the life of one in five children dying from respiratory infectious diseases.”

A 2004 study by UNICEF showed that that pneumonia killed at least 132,000 children under the age of five in DRC, making it the second biggest cause of death – after malaria – of children under the age in the country.

“With electricity, roads, and refrigerators in short supply, delivering vaccines to remote health centres in DRC is an enormous challenge,” said Pierrette Vu Thi, the UNICEF Representative in DRC. “Together with its partners UNICEF is committed to ensure that all children in this country have the same access to this life-saving vaccine.”

In the past five months, Nicaragua, Guyana, Yemen, Kenya, Sierra Leone, and Mali also introduced pneumococcal vaccines thanks to support from GAVI.

UN News Center

Share

Canadians Make Malaria Breakthrough

Mother and daughter sleep under mosquito net to prevent bites from the parasite carrying mosquito

Lana Haight, Postmedia News

SASKATOON — Scientists in Saskatoon have developed an inexpensive malaria treatment that will help the million people who die every year from the infection.

“This is the most important drug in the treatment of malaria today. The World Health Organization says it should be the first line of defence,” said Patrick Covello, a senior research officer at the National Research Council in Saskatoon.

Covello and his team figured out a way to produce a difficult-to-cultivate chemical needed to build effective malaria drugs.

The breakthrough was announced Friday at the National Research Council Plant Biotechnology Institute.

The best drugs available to fight malaria are made with artemisinin, a compound derived from the sweet wormwood plant found in parts of Asia and Africa. But cultivating and harvesting the plant and then extracting artemisinin is time-consuming and labour intensive, says Covello. And the supply of the natural compound is also dependent on weather and growing conditions.

In 2003, Covello began work to identify the genes in the wormwood plant that produce the protein that leads to artemisinin.

“We identified four genes in what we call the pathway to artemisinin in the plant,” he said in an interview.

Meanwhile, University of California at Berkley researchers found they could develop a precusor to artemisinin by introducing chemicals into yeast.

Covello contacted Amyris Technologies, a spinoff company from the Berkeley research group, to suggest it use the genes his group had identified in the wormwood plant. When two of the genes identified in Saskatoon were introduced to the yeast compound developed at Berkeley, the production of artemisinin doubled.

The Institute for OneWorld Health, the American-based organization that has led the project to develop the semi-synthetic artemisinin, and pharmaceutical company Sanofi-aventis jointly announced on Friday that the drug company is preparing to ramp up production using the genes identified in Saskatoon.

The Bill & Melinda Gates Foundation, which has already contributed $42.6 million toward the American research, is also supporting the production of the drug to ensure it will be available on a not-for-profit basis for the developing world.

“The idea is to provide the developing world with antimalarial drugs at the lowest possible cost and, in addition, to provide a very stable supply because this yeast-fermentation process is shorter term and more reliable than growing the plants themselves,” said Covello.

Covello understands that Sanofi-aventis will begin commercial-scale production in 2012.

The federal government has spent $869,000 over eight years to support the Saskatoon research.

“Our government is committed to improving the health of women and children in developing countries,” said Gary Goodyear, minister of state for science and technology, in a government news release.

“This new development in the production of a malaria treatment represents a major development in the fight against the disease. It will strengthen Canada’s position as a world leader in health research and provide a reliable and affordable solution.”

The Vancouver Sun
Share

Africa: Experts Seek WHO Nod for Postpartum Haemorrhage Drug

UN Integrated Regional Information Networks (IRIN) -March 17, 2011

Dakar (Senegal) — A drug many health experts say can drastically cut postpartum haemorrhage – the leading cause of maternal deaths in the developing world – will be in the spotlight this month during the World Health Organization’s (WHO) biennial review of its model list of essential medicines.

Health groups are urging WHO to include misoprostol for the prevention and management of postpartum haemorrhage (PPH), or excessive bleeding following childbirth. WHO in 2009 denied misoprostol for prevention of PPH but proponents hope new evidence presented for the 21-25 March WHO meeting in the Ghanaian capital Accra will bring a change.

An advantage of misoprostol for treating PPH in developing countries is that it is stable at room temperature and can be administered in tablet form, experts say. The primary drugs for PPH – oxytocin and ergometrine – need refrigeration and are injected. While oxytocin is cheaper, misoprostol is more cost-effective in many settings because of these other features, say health experts in their application to WHO.

Such drugs – called oxytocics – cause the uterus to contract, speed up delivery of the placenta and lessen blood loss.

“It is simply pragmatic – I am 100 percent in support of including misoprostol among our means for preventing or treating PPH until we get a better option,” Lawal Oyeneyin, chief medical director at Mother and Child Hospital, Akure, Ondo State, Nigeria, told IRIN. He is among several who submitted letters of support.

PPH causes about a quarter of maternal deaths worldwide, according to WHO; Oyeneyin said it is “without a doubt” the most common cause of maternal death in Ondo State. “Why exclude misoprostol when the benefits outweigh the risks?”

Médecins Sans Frontières also wrote in support of the drug. “Oral misoprostol is a useful alternative for injectable oxytocics when they are not available or ineffective,” said MSF international medical coordinator Myriam Henkens.

The essential medicines list (EML) is a guide for national and institutional essential medicines, according to WHO. While governments are not bound to follow it, the model list heavily influences national health ministries, experts say.

In rejecting the drug last time, WHO said some adverse effects were not well understood; the agency says further study is needed into safety and efficacy. It recommends the use of misoprostol in settings where it is not possible to use oxytocin or another injectable uterotonic, but it was not put on the list because trials had not proven efficacy; shivering and fever can occur, and “there is an unresolved concern of a possible increase in the risk of maternal mortality”.

Five years ago Nigeria became the first country to include misoprostol for PPH among its essential medicines. Some governments find it difficult to do so because it is not on WHO’s list, Oyeneyin said.

Listing misoprostol for PPH prevention “will break down this barrier”, proponents say in letters to WHO.

Anthony Smith, emeritus professor of clinical pharmacology at Calvary Mater Hospital in New South Wales, has done several consultancies with WHO, particularly in the Pacific Islands.

“While oxytocin and ergometrine appear to be modestly superior to misoprostol in clinical trials, misoprostol is efficacious in its own right and is stable under hot conditions. Until such time as dependable storage exists for oxytocin and ergometrine, misoprostol will provide acceptable treatment for the prevention and treatment of PPH in these remote, hot locations,” he said.

If we were ever to remove this drug from communities there would be riots

Misoprostol is a generic product and has several manufacturers. It was developed in the 1980s and approved in the US for prevention of gastric ulcers but has been used since in obstetrics and gynaecology. It is used in combination with mifepristone to terminate a pregnancy. Some health workers warn about misuse.

Getting misoprostol on the EML would be a step forward but just one step, according to proponents. They say the drug should be in the hands of community health workers and pregnant women, not uniquely at medical facilities. While having more women give birth in properly equipped clinics with skilled medical staff is the ideal for mother and infant health, experts say, this remains far from the reality for most women in rural sub-Saharan Africa and Asia.

“Where I work [in Kaduna and Zaria states] more than 90 percent of births take place at home; in Nigeria about two-thirds,” said Clara Ejembi, from the department of community medicine at Ahmadu Bello University, Zaria State. In some cases home delivery is preferred – either because of custom or the quality of health facilities.

Nigeria is now revising guidelines on misoprostol to add advice on community use. Ghana, Senegal and Tanzania are also studying community access to misoprostol. The US Agency for International Development (USAID), which calls misoprostol “a highly promising technology that may be used by trained health workers working outside facilities and even in remote areas”, is testing and introducing misoprostol in Afghanistan, Bangladesh, Nepal and Senegal.

However, WHO has expressed concern about advanced community distribution of misoprostol. Matthews Mathai of WHO’s Making Pregnancy Safer programme told IRIN: “There is evidence that incorrect dosing can lead to excessive and violent contractions of the uterus leading to foetal distress, foetal death and uterine rupture.”

Nigerian doctor Oyeneyin said the incorrect usage concern should not rule out access. “Opponents are worried about the safety profile of misoprostol. But the safety issue can be addressed through training.

“When you have a problem you should use all ammunition available to tackle it – in this case, that’s oxytocin, ergometrine and misoprostol,” he said. “It’s ironic that the first two are on the model list of essential medicines while misoprostol is not. Of the three, misoprostol is most likely to be applicable in communities.”

Godfrey Mbaruku, deputy director of Ifakara Health Institute in Dar es Salaam, Tanzania, said misoprostol must not be seen as a panacea, as PPH is not the only complication that can arise. “The idea is not to encourage women to deliver at home,” he told IRIN. “But this allows them to have the drug on hand in case of PPH during a home delivery.”

In northern Nigeria where home births prevail, research has shown that distributing misoprostol in the communities is a viable approach, Ejembi said. “Among community leaders acceptance is very high; people are ready to use this and advocate it. WHO people should come and let me take them around to the communities so they can hear the people’s voices.”

She said women in the communities where she works recognize the value of misoprostol. “If we were ever to remove this drug from communities there would be riots.”

Share

What I would Talk About if I Were a Celebrity: Spousal Rape

Valentine Day is about love, chocolate and kisses.  Mother’s Day is about extravagance, breakfast in bed and Women’s Fellowship service at church. International Women’s Day is about serious issues with dire consequences for millions of women in hundreds of countries. Marital or spousal rape is one.  The first celebration of International Women’s Day occurred on March 19, 1911, 100 years ago. Before this period, employers had their choice whether to hire women and most governments in the world, including the U.S. and Canada, prohibited women from voting. In fact, employers who decided to have anything at all to do with women relegated them to the sweatshop.

Significant progress has been made over the past hundred years but huge challenges remain for the women of today. On this anniversary, a lot has been written by more qualified experts to address some of these challenges women face. If I were a celebrity or a popular figure who people listen to, what I would love to write or talk about would be spousal rape or marital rape which occurs in several African communities and many countries.

Marital rape or spousal rape is an issue that has received very little attention internationally. I want to admit that the first time I heard the term ‘marital rape’, it sounded an oxymoron or a paradox. It was like hearing “useless treasure”, “precious garbage” or “holy dirt”. I asked myself how someone could be raped by her own partner. Isn’t that what the relationship is for?

There are millions of people, some highly educated, some not, who hold the mentality that I had. In many communities in many countries, when a woman (girl or adult) is forcibly made to have sex, it is reported as rape. No problem.  When a husband forcibly pounces on his wife and has sex with her, even when she’s least ready and least expecting it, that’s no news. She’s just the wife. In fact, journalist, don’t even cover it. Marital rape does not get any attention but it happens every single day. In many countries around the world, marital rape is either legal, or illegal but widely tolerated and accepted as a husband’s prerogative.

In a 2008-2009 Kenya Demographic and Health Survey, the report states that “at least 14 percent of married women said their current husband or partner had forced them to have sex in the past year, while another 37 percent had been subjected to sexual violence at some point in their relationship”. That is 14 out of every 100 women surveyed said their husbands had entered them forcibly in one year. And 37 women out of 100, overall! That is nearly 4 out of every 10 women! Again a World Health Organization conducted a study on violence against women in Tajikistan and Turkey. In Tajikistan they surveyed 900 women above the age of 14 and found that 47% of married women reported having been forced to have sex by their husband. In Turkey 35.6% of women had experienced marital rape sometimes and 16.3% often.  How many of these were reported? How many were covered in the evening news? And how many appeared in the local newspaper? Perhaps none. The societies accept these social behaviors and actually women who come out and report these behaviors will be stigmatized. A politician wouldn’t want to waste an ounce of their effort fighting such an irrelevant matter.

As we celebrate the international women’s day, I’ll end this by suggesting a few actions that governments, non-governmental organizations (NGOs) and communities need to take to protect the rights and dignity of women in relationships.

  • Embark on aggressive community campaigns to educate the citizenry on what sexual violence and rape in marriage implies
  • Empower the women to assert their rights and report what they perceive as rape or other forms of sexual violence
  • Enact laws to police marital or spousal rape and related violence
  • Train and provide health care professionals at the hospital who can identify what rape and other sexual violence are, who know what the law is, and how to enforce it and can show the women how to move forward. Since some of these women will eventually end up at the hospital or clinic with lacerations and other ‘fingerprints’ this will be an effective method to identify women who may have been abused.

I wish all women a Happy Women’s Day. Violence against women is violence against civilization.
[ad#Adsense-468×60]

Share

Smart Steps to Healthy Living

Whether rich or poor, many people fail to see the link between their habits and their health. They may regard enjoying good health as a matter of chance or something over which they have little control. Such a fatalistic view holds many back from improving their health and leading a more productive life.

In reality, whatever one’s financial situation, there are basic steps that can be taken to protect and improve ones health and those of close associates. Some common healthy habits are provided below:

EAT WISELY– Concentrate on eating ‘real’ food- whole, fresh foods that people have been enjoying for millenniums- rather than modern processed foods. Commercially prepackaged foods and fast food from chain restaurants usually contain high levels of sugar, salt, and fat which are associated with heart disease, stroke, cancer and other serious ailments. When cooking, try steaming, baking, and broiling instead of frying. Try using more herbs and spices to cut down on salt. Make sure meats are properly cooked, and never eat spoiled foods.

The World Health Organization reports a dangerous worldwide increase in overweight and obesity, most of which result from overeating. One study found that in parts of Africa, ”there are more children who are overweight than malnourished”. Obese children carry both present and future health risks including diabetes. A balanced plate favors a variety of fruits, vegetables, and whole grains over meats and starches. Once or twice a week, try substituting fish for meat. Reduce refined food such as pasta, white bread, and white rice, which are usually stripped of much of their nutritional value. Adults and children need to drink plenty of water and other unsweetened liquids every day. Drink more of this during hot weather and when doing heavy physical exercise. Such liquids aids digestion, and cleanse the body of poisons, make for healthier skin, and facilitate weight loss.

TAKE CARE OF BASIC BODY NEEDS– The demands and distractions of modern life have whittled away the time people spend sleeping. But sleep is germane to good health. Studies have shown that during sleep, our body and brain repair themselves, which benefiting memory and mood. Sleep reinforces the immune system and reduces our risk of infections, diabetes, stroke, heart disease, cancer, obesity, depression and so on. Most adults need seven to eight hours of sleep every night to feel good and perform their best. Young people need more.

KEEP YOURSELF MOVING– Leading a physically active life can help us feel happier, think more clearly, have more energy, be more productive and, along with proper diet, control our weight. Exercise needs not be painful or extreme to be effective. Regular periods of moderate exercise several weeks can be beneficial. Jogging, brisk walking, biking can help prevent heart attack and stroke. Simply using your feet instead of a car, bus or elevator is a good step. Why wait for a ride when you can walk to your destination? No matter how old you are and when you start, you can benefit from moderate physical exercise. If you are older or have health problems and have not been exercising, it is wise to consult a doctor about how to begin. But do begin! Exercise that is started gradually and not overdone can help even the oldest to maintain muscle strength and bone mass.

PROTECT YOUR HEALTH– ”Hand washing is the single most important thing that you can do to help prevent the spread of infections and stay healthy and well”, reports the U.S Centers for Disease Control and Prevention. As much as 80 percent of infections are said to be passed on by unclean hands. So wash them often throughout the day. Do so especially before eating, preparing food, or dressing or even touching a wound, and do so after touching an animal, using the toilet, or changing a baby’s diaper. Washing with soap and water is more effective than using alcohol-based hand sanitizers. Bathing everyday and keeping one’s clothes and bed linens fresh and clean also contribute to better health. Avoid close physical contact or sharing of eating utensils with any who have a cold or the flu. Their saliva and nasal secretions can pass the illness to you. Avoid insect bites. Do not sit or sleep outdoors unprotected when mosquitoes or other disease-carrying insects are active. Use bed nets especially for children, and use repellents. Make whatever effort is required to keep your home clean, inside and out. If there is no toilet, build a simple latrine rather than just relieving yourself in a field. Cover the latrine to keep out flies. Obey safety laws when working, riding a bicycle or motorcycle, or driving a car. Use appropriate protective equipments such as safety glasses, headgear, and footwear, as well as seat belts and hearing protection. Avoid excessive sun exposure, which causes cancer and premature aging of the skin.

(excerpts from AWAKE journal- march, 2011)[ad#Adsense-468×60]

Share

New pneumonia vaccine targets leading cause of child deaths worldwide – UN

14 February 2011 –Hundreds of infants in Kenya received their first shots against pneumococcal disease today at a special United Nations-backed event to celebrate the global roll-out of vaccines targeting the world’s leading cause of child deaths – pneumonia.

President Mwai Kibaki joined parents, health workers, ambassadors and donors in Nairobi to witness children being immunised as part of the Government’s formal introduction of pneumococcal vaccine in its routine immunisation programme for all children.

Kenya is the first African country to introduce the pneumococcal conjugate vaccine which has been tailored to meet the needs of children in developing countries.

Nicaragua, Guyana, Yemen and Sierra Leone are also rolling out the vaccine with support from the Global Alliance for Vaccines and Immunisation (GAVI) which brings together governments, the UN Children’s Fund (UNICEF), the World Health Organization (WHO) and other key players in global health.

Pneumococcal disease currently takes the lives of over a million people every year – including more than half a million children before their fifth birthday.

Pneumonia is the most common form of serious pneumococcal disease and accounts for 18 per cent of child deaths in developing countries, making it one of the two leading causes of death among young children.

“The pneumococcal vaccine can help us to dramatically reduce the number of children who die from pneumonia, a killer disease that is responsible for millions of deaths globally every year,” said UNICEF Executive Director Anthony Lake.

“By combining the power of immunisation with other measures like better nutrition and sanitation, we can change – and save – millions of children’s lives.”

The GAVI Alliance has committed to support the introduction of pneumococcal vaccines in 19 developing countries within a year and, if it gets sufficient funding from its donors, plans to roll them out to more than 40 countries by 2015.

WHO Director-General Margaret Chan noted that the rapid roll-out of the pneumococcal vaccine shows how innovation and technology can be harnessed, at affordable prices, to save lives in the developing world.

“The payback, as measured by reduced childhood mortality, will be enormous,” said Dr. Chan.

GAVI needs an additional $3.7 billion over the next five years to continue its support for immunisation in the world’s poorest countries and introduce new and underused vaccines, including the pneumococcal vaccine and the rotavirus vaccine which tackles diarrhoea – the second biggest killer of children under five.

“Routine vaccination is one of the most cost-effective public health investments a government can make and we are counting on our donors to continue their strong backing for our life-saving mission,” said Helen Evans, interim CEO of the GAVI Alliance.

Since it was launched at the World Economic Forum in 2000, GAVI has prevented more than five million future deaths and helped protect 288 million children with new and underused vaccines.

Share

African Anti-malaria Initiative Offers Good Model for Tackling Other Ills, Un Chief

31 January 2011 –Secretary-General Ban Ki-moon today highlighted the success achieved by the African Leaders Malaria Alliance (ALMA) in saving thousands of lives across the continent, saying it offers a good model for tackling other social ills.

“The African Leaders Malaria Alliance is breaking down barriers, forging partnerships and getting supplies to families in record time,” Mr. Ban said in remarks at the ALMA event in Addis Ababa, Ethiopia, on the sidelines of the summit meeting of the African Union.

“This is remarkable progress. We need to encourage it and use the response to malaria as a model for battling other illnesses and social ills,” he added.

Malaria kills almost one million Africans every year and affects over 200 million more, mostly pregnant women and children under five years of age, resulting in at least $12 billion of costs every year through lost development and opportunity.

Launched in September 2009 in New York, ALMA is a high-level forum set up to oversee the efficient procurement, distribution, and utilization of malaria control measures, with the aim of ending unnecessary deaths from the disease by 2015.

“This alliance against malaria is stopping the disease and saving thousands of lives. It is a great success story. You are bringing us closer to our Millennium Development Goal on malaria and showing how we can reach all the MDGs: with commitment at the highest level,” Mr. Ban stated, referring to the goal of halting and reversing the incidence of malaria by 2015.

Just last month, the UN World Health Organization (WHO) announced that malaria deaths declined by 10 per cent between 2008 and 2009. In 11 African countries, the disease’s deadly toll has been cut by more than half since the year 2000.

“Just as malaria is carried by a mosquito that goes from person to person, so does our campaign seek to reach people just as directly,” said the Secretary-General. “We want to give every community health worker, every family, every child the tools and protection they need.

“We’ve delivered over 290 million nets to Africa since 2008. More nets and treatments are on their way. Universal coverage is not just a hope; it is within our reach.”

UN News
Share